Deals this week: Dova Pharmaceuticals Inc, Gamida Cell Ltd, Onxeo SA

US-based clinical-stage pharmaceutical company Dova Pharmaceuticals Inc is intending to raise between $60.93m and $69.06m through an initial public offering (IPO) of 4,062,500 shares of its common stock.

Source: Drug Development Technology - June 22, 2017 Category: Pharmaceuticals Source Type: news